| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |